ELTX 8-K: SEC filing
Elicio Therapeutics
Filed with the SEC on · accession 0001601485-26-000065
ELTX filed a 8-K (current report) with the SEC on Nov 5, 2026. A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The stock moved -10.3% by the first close after the filing.
Summary of the filing
Elicio Therapeutics announced its financial results for the quarter ended September 30, 2026, and provided corporate updates via a press release furnished as Exhibit 99.1 to this Form 8-K.
Key details
How ELTX stock reacted
Close before
$1.56
Nov 4, 2026
First close after
-10.26%
$1.40
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for ELTX, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for ELTX?
Click hereFrequently asked questions
What did ELTX file with the SEC on Nov 5, 2026?
ELTX filed a 8-K (SEC filing). Elicio Therapeutics announced its financial results for the quarter ended September 30, 2026, and provided corporate updates via a press release furnished as Exhibit 99.1 to this Form 8-K.
How do I read a 8-K?
A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.
How did ELTX stock react to this filing?
ELTX closed at $1.56 before the filing and $1.40 on Nov 5, 2026 (-10.26%).
Other ELTX SEC filings
Get alerts when ELTX files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days